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In the periplasmic space of F.sche~'ichia coil, the (L)-m-A,pm-(D)-m-A,pm pcptid¢, the lipoprotein, and the AmpC fl-lactamas¢ are controlled by 
growth rate. To explain this coordinate r gulation, it is proposed that the AmpC protein functions as an LD-endopeptidase in addition to its known 
function as a fl-lactamas¢. As LD-peptides, vo-peptides and fl-lactams are structurally similar, to-peptidases may belong to the larger family of 
DD-peptidases and serine ~-lactamases. In contrast o K coll. many related bacteria possess an inducible AmpC protein. Several gene systems 
necessary for AmpC induction are known to affect various aspects of peptidoglyean metabolism, It is proposed that AmpC induction ¢o=urs 
indirectly via a recyclabl¢ e¢ll wall pcptid¢. 
Penicillin; Pcptidoglyean;/~.Laetamase; Murein peptidase; Murein lipoprot¢in; Transcription regulation 
1. INTRODUCTION 
The cell wall of Escherichia coil is composed of an 
outer membrane arid a rigid exoskeleton called the 
murein sacculus which determines cell shape and pro- 
tects the bacterium from osmotic lysis. The murein layer 
lies within the periplasmic space which separates the 
outer membrane from the inner cytoplasmic membrane. 
Since the murein is continuously remodelled as the bac- 
terium grows and divides, its synthesis tightly coordi- 
nated with the cell division cycle. Additionally, since the 
murein is both essential and unique to bacteria, the 
enzymes of murein metabolism are import~-i~t targets of 
antibiotic action. Penicillins and related/~-iactam nti- 
biotics are selective inhibitors of the penicillin-binding 
proteins (PBPs) which are enzymes of murein biosyn- 
thesis (reviewed in [1]). 
The PBPs construct murein from peptidoglycan pre- 
cursors which are synthesized in the cytoplasm. The 
structure of the peptidoglycan that becomes incorpo- 
rated into the murein layer of E. coli is shown in Fig. 
1. Glycan chains of alternating N-acetylglucosamine 
(GlcNAc) and N.acetylmuramie acid (MurNAc) are 
linked by ,6-1,4-glycosidic bonds. The glycan chains are 
interconnected by short peptides which are attached by 
amide bonds to the carboxyl group of each MurNAc 
residue. In ¢nterobacteria, the cell wall peptides are de- 
rived from the pcntapeptide L-alanyl-I)-7,-glutamyl-(L)- 
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meso-diaminopimelyl-D-alanyl-D-alanine (L-ala-D-?- 
glu-(L)-m-A2pm-o-ala-D-ala) [1].
Soon after peptidoglycan is incorporated into the gly- 
can network of the murein, the terminal ~ala-i>-ala 
peptide bond is cleaved by a Do-peptidase. The enzyme 
catalyzes nucleophilic displacement between an active 
site serine hydroxyl group and the carbonyl carbon of 
the peptidv to form an intermediate acyl--enzyme. The 
carbonyl carbon of the acyl-enzyme ester bond then 
reacts with an acceptor nucleophile which regenerates 
the active ~erine nzyme and releases the modified pep- 
tide. The oo-transpeptidases employ the e-amino group 
of a neighboring m-A_,pm residue as aeceptor to form 
a D-ala-(o)-m-A2pm cross-link which interconnects the 
glyean chains of the murein saeculus (Fig. 1). Approxi- 
m~tel,., one quarter of the cell wall peptides in E. coti are 
cross l-nged by transpeptidation [!]. The DD-car- 
boxypeptidases employ water as an acccptor and 
thereby convert the remaining pentapeptides to 
tetrapeptides; the D-ala-(D)-m-A,pm cross-link is struc- 
turally similar to D-ala-D-ala and subject o hydrolysis 
by a DD-endopeptidase. These murein hydrolases are 
necessary for cell growth and division since they help 
maintain the dynamic structure of the murein saeculus 
(reviewed in [2]). The family of DD-peptidases are inac- 
tivated on binding penicillin. 
The molecular basis of penicillin action was predicted 
by Tipper and Strominger in 1965; they observed that 
penicillin is a structural analog of the D-ala-v-ala termi- 
nus of cell wall peptides [3]. Indeed, if the reactive amidc 
bond in the fl-lactam ring of penicillin is superpomd on 
the seissile peptide bond of acyl-D-ala-D-ala, the ,,-car- 
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bon backbone of the peptide can adopt a conformation 
that is nearly isosteric with penicillin. Tipper and 
Strominger suggested that transpeptidation mlght pro- 
ceed by an acyl-enzyme mechanism which conserves the 
D-ala-D-ala bond energy needed to form a pcptide cross- 
link in the extracytoplasmic milieu [3]. They al;;o pro- 
posed that penicillin may exert its antibiotic properties 
by acylating the active site o fa  t)D-peptidase to lbrm an 
inactive penicilloyl enzyme [3]. An important corollary 
was that fl-lactamases, which hydrolyze the fl-lactam 
amide bond, may be derived from the DD-peptidases [3]. 
It has since been demonstrated that DD-peptidases 
and serine #-lactamases catalyze amide bond cleavage 
via an acyl-enzyme mechanism which involves an active 
site serine residue located at the junction of two do- 
mains (reviewed in [4]). In the presence of penicillin, the 
Dp-peptidases form a stable penicilloyl enzyme, whereas 
the serinefl-lactamases f rm a penicilloyl enzyme which 
is hydrolytically labile. Since Dt)-peptidases and serine 
~-lactamases of class A and C exhibit similar tertiary 
structures, it is now believed that they evolved diver- 
gently from an ancestral enzyme [5]. However, the 
serine fl-lactamases of class A are distinct from the class 
C enzymes (AmpC) [5]. Some relationships between 
peptidoglycan structure and the regulation of entero- 
bacterial AmpC ~ynthesis are difficult to interpret in 
terms of the DD-peptidase analogy. This article will de- 
scribe these relationships and interpret hem by analogy 
with LD- peptidases. 
2. METABOLISM AND PHYSIOLOGY OF 
LD-PEPTIDES 
As the murein matures, the (L)-m-A.~pm-D-ala peptide 
bond in cell wall tetrapeptides can be ruptured by sev- 
eral L~)-peptidases. The LD-carboxypeptidasa of £. coli 
is insensitive to penicillin although it is inhibited by 
nocardicin A, a monocyelie ,8-1actam which interacts 
with the enzyme non-covalently [6]. It has been pro- 
posed that D-amino acids and a related substituent in 
nocardicin A arc important for Lo-carboxypeptidase in- 
hibition [7]. No mutants in the LD-carboxypeptidase 
gene are available nor has the enzyme been character- 
ized structurally. However, it is probable that the LD- 
carboxypeptidase operates by an acyl-enzyme mecha- 
nism analogous to that of the no-carboxypeptidases. 
The Lo-carboxypeptidase produces murein tripeptides 
which are preferentially used as aeceptors by PBP3, a 
oo-transpeptidase required for septatio:~ [8]. It is possi- 
ble that the L~-carboxypeptidase i  coordinated with 
septation s in~ ~ts expression is elevated at the time of 
cell division [9]. 
The (L)-m-A:pm-D-ala peptide bond is also important 
for attachment of  Braun's lipoprotein to the murein 
saceulus. Approximately one third of lipoprotein mole- 
cules in E. coli are covalently attached through the e- 
amino group of their C-terminal ysine to the (L)-m- 
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Fig. 1. Structure of the principle disaeeharide p ntawptid¢ precursor 
~vhieh is incorporated into the murein layer of £schvrichia coll. rm. 
Transpcptidases catalyze acyl-transfer between the carbonyl carbon 
of the tcrrninal t~-ala-n-ala peptid¢ and the ~-amino group of a neigh- 
boring A.,prn rcsldu¢ to form a peptide cross-link, nD.Carboxypcpti- 
doses transfer the acyl group to water, and a ot~.endop~ptidase rup- 
tures the pcptide cross-link (see t~xt for discussion). 
A2pm residue of a murein tripeptide [10]. By analogy 
with DD-transpeptidases, the putative (L)-m-A,pm:lipo- 
protein transpeptidase may catalyze nucleopbilie dis- 
placement of' the (i)-m-A~pm-D-ala peptide bond to 
form an acyl--cnzyme which employs the lipoprotein as 
an acceptor. In mutants of E. coli and Sahnonella ty- 
phimur/um with decreased levels of murein-bound lipo- 
protein, the outer membrane fails to invaginate with the 
murein layer during septation [11,12]. However, a mu- 
tant of t7,, toll that lacks the lipoprotein grows and 
divides normally; the abnormally leaky outer mem- 
brane of this mutant suggests the lipoprotein helps 
maintain the integrity of the cell wall [13]. 
Recently, a novel (L)-m-A~pm-(o)-m-A2pm peptide 
fltat comprises a small fraction of murein cross-links 
xas discovered in E. coll. It has been suggested that an 
LD-transpeptida~e may catalyze nucJeophilic displace- 
ment of the (L)-m-A2pm-p-ala peptide to form an acyl- 
enzyme which employs the e-amino group of a neigh- 
boring m-A2pm residue as an acceptor [14]. It has also 
been suggested that the Lo-transpeptidase and the (L)-m- 
A.~pm:lipoprotein transpeptidase may be identical since 
the lipoprotein is initially attached preferentially to cell 
wall peptide.~ in which the m-A2pm residue participates 
in a cross-link [15]; the (L)-m.A,pm.(o).m.A:pm cross- 
links that carry the lipoprotein are twice as abundant as 
the lipoprotein-free species [16]. Additionally, the (L)-m- 
A2pm-(D)-m-A:pm peptide bond and the murein lipo- 
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protein are the only murein structures regulated by bac- 
terial gro,nh rate; their abundance decreases coordi- 
nately with increasing rowth rate [17]. This may reflect 
the activity of an LD-endopeptidase which could modu- 
late the availability of (L)-m-A,,pm-(D)-m-A2pm peptides 
for lipoprotein attachment and liberate lipoprotein- 
tripeptides from the cross-linked species. 
3, GROWTH RATE CONTROL OF AmpC SYN- 
THESIS AND MUREIN  STRUCTURE 
The AmpC fl-lactamase of E. coli is specifically ex- 
pressed in direct proportion with growth rate [18]. The 
chromosomal mpC gene is controlled by a promoter 
which lies within the coding sequence ofthe neighboring 
and overlapping fumarate reductase operon (frd) [19]. 
Transcription of the ampC gene is initiated through the 
frd terminator, also known as ampA, which functions 
as an ampC attenuator. Anti-termination is occasionally 
achieved when the translational pparatus couples with 
a ribosome-binding sequence in nascent ampC tran- 
scripts [20]. Since ribosome biogenesis independently 
coordinated with growth rate by the Stringent Re- 
sponse, AmpC expression is coordinated with growth 
rate by the amp/l attenuator [20]. The ampC gene is not 
induced by fl-lactam compounds and, in the absence of 
rare mutations that lead to AmpC overproduction, is 
not normally an agent offl-lactam resistance [21,22]. 
The role of growth rate in control of ampC gene 
expression remains an enigma. However, the phenome- 
non of phenotypic tolerance, whereby slowly growing 
bacteria re more resistant to the killing action of peni- 
cillin, may partly result from structural changes in the 
cell wall [23]. The ampA attenuator provides levels of 
AmpC protein that are exactly inversely proportional, 
over similar growth rates, to levels of both the (L)-m- 
A~_pm-(n)-m-A,pm peptide and the lipoprotein (com- 
pare [17] and ~18]). To the same degree, cell diameter in 
E. coli is also inversely proportional to growth rate [24]. 
In Sahnonella typhOnurium, which lacks an ampC gene, 
no correlation between growth rate and cell diameter is
evident [25]. The coordinate control of ampC gene ex- 
pression and rnurein composition in E. cob could be 
explained if the AmpC protein functions as the putative 
t.D-endopeptidase. 
4. STRUCTURAL SIMILARITIES BETWEEN 
CELL WALL PEPTIDES 
Is it possible that the AmpC protein functions both 
as a fl-lactamase and an LD-peptidase? As demonstrated 
in Fig. 2, the (L)-m-A,pm-(D)-ala peptide is a stuctural 
analog of the D-ala-o-ala peptide and of penicillin. Due 
to the D-configuration of the 8-carbon in m-A:pm, the 
two endopeptide cross-links are analogous to their cor- 
responding exopeptides. Therefore, the DD-peptides and 
the LD.-peptides can be largely superposed on each other 
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Fig. 2. Structural similarity between c¢11 wall peplides and penicillin. 
Enboldened atoms in the e,..carbon backbone~ of the ~-peptide (top) 
and the Do-peptide (bottom) can be superposed on the re.active amide 
bond in the fl-lactam ring of benzyl penicillin (middle). S~bstituent~ 
that differ between the three amid¢ classes arc outlin~l (~.~ text for 
discussion). 
and on penicillin. This relationship suggests that D~ 
peptidases, LD-peptidases and serine p-laetamases cata- 
lyze the cleavage of similar amide substrates and may 
thereby comprise a single family of enzymes which 
evolved ivergently from a primordial murein amidase. 
Structural differences between the rnurein peptidases 
may reflect he structures of their corresponding peptide 
substrates and the origins of the different classes of 
serine fl-lactamases. The position that corresponds to 
the ~-carbon on the 6-p-aminoaeyl side chain of penicil- 
lin is not substituted in the L~peptide (Fig. 2). Gener- 
ally, fl-lactams that lack substituents at this position 
exhibit higher turnover numbers than their substituted 
counterparts due to hydrolysis by class C fl-lactamases 
[26]. The major secondary structural elements of t;D- 
peptidases and serine fl-lactamases can be superposed 
on each other. An important structural difference, 
which may somehow influence substrate recognition, is
the inverted orientation of helix ~10 in the class C fl- 
laetarnase [5]. These relationships support he concept 
that the AmpC protein may recognize both p-lactams 
and LD-peptides as substrates. 
An alternate LD-peptid¢ hypothesis was originally 
proposed by Wise and Park; they demonstrated that 
penicillin is a structural analogue of the L-ala-~?'-glu 
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peptide [27]. However, k-ala-D-y-glu is not a substrate 
for any known peptidases and it is unable to adopt the 
conformation that mimics penicillin and D-ala-D-ala 
[28]. The fact that the LD-carboxypeptidase is not inac- 
tivated by penicillin [6] may either reflect a conforma- 
tional difference between penicillin and (L)-m-A,pm-D- 
a[a or an ability of the kD-carboxypeptidase to hydro- 
lyze penicillin. Pollock originally proposed that some 
fl-laetamascs may have retained an additional metabolic 
function which has escaped etection [29]. The overrid- 
ing importance of the AmpC protein as a ,8-1actamase 
may reflect a relatively benign function of (u).m-A.,pm- 
(t))-m-A2pm peptides in cell wall metabolism. Addition- 
ally, Saz suggested a role for fl-lactamases in cell wall 
turnover based on studies of an inducible chromosomal 
fl-lactamase in sporeforming bacteria [30]. In many bac- 
teria related to E. coil, the chromosomal mpC gene is 
inducible and relationships between ampC induction 
and murein metabolism are evident. 
5. CONTROL OF THE INDUCIBLE AmpC ]~-LAC- 
TAMASE 
In Gram-negative bacteria such as Enterobacter cloa- 
cae, Citrobacter freundii and Pseudomonas erughlosa, 
the chromosomal mpC gen¢ is induced by ,8-1aetam 
antibiotics [31--33]. Induction depends on the ampR 
gene which separates ampC from rid, and thereby re- 
places the ampA attenuator rE. coli. The ampRC locus 
constitutes a divergently transcribed control unit 
wherein the AmpR protein binds specifically to the in- 
tergenie operator az~d represses transcription of both 
genes [31]. In the presence of ,8-1actam compounds, 
AmpR is somehow converted to an activator of ampC 
gene expression. AmpR belongs to the LysR family of 
DNA-binding transcriptional regulators, many of 
which are controlled by binding specific ligands [34]. It 
is unlikely that penicillin controls AmpR directly be- 
cause the primary structure of AmpR lacks the fl-lactam 
binding motifs that are common among the PBPs and 
the serine/~-lactamases [31]. Additionally, induction of 
the ampC gene does not require that p-lactams penetrate 
the cytoplasmic membrane [35]. Therefore, a signal 
transducing second messenger p obably mediates infor- 
mation from the cell envelope to the ampC transcrip- 
tional apparatus. 
Mutations that affect control of the inducible atnpC 
gene have revealed important aspects of the induction 
mechanism. The ampD mutation has been identified 
both in E. coli transformznts hat harbor the cloned 
ampRC locus in a recombinant plasmid and in Entero- 
bacter cloacae [36,37]. The ampRC transformants of E. 
coli normally express the plasmid-encoded ampC gene 
in a ,8.1actam.inducible manner. In the presence of ,8- 
lactam antibiotics, the ampD mutation is selected at a 
high frequency in the inducible bacteria; these mutants 
exhibit stably derepressed AmpC expression and ex- 
treme resistance to ,8-1attains [36,37]. In E coli, the 
ampD mutation maps to an operon that encodes an 
additional downstream gene named ampE [38,39]. The 
AmpE anaino acid sequence shares similarities with a 
family of membrane-localized bacterial transport pro- 
teins, which include the oligopeptide permease (Opp), 
whereas AmpD is a cytoplasmic protein [39]. 
The non-inducible ampC gene of the E. coli chromo- 
some is unaffected by the ampDE operon. However, 
ampD mutants of E. coli accumulate cell wall peptides 
in the growth medium [40]. Additionally, in the simulta- 
neous presence of exogenous A.,pm and a functional 
ampD genes E. coli increases the number of pentapep- 
tides in the murein; this implicates ampD in the general 
regulation of murein carboxypeptidase activity [40]. In 
the inducible bacteria A,pm functions as a non-specific 
inducer of AmpC expression [41]. These data suggest a
dual role for the ampDE opcron in control of cell wall 
peptide metabolism and regulation of Ar~pC induction. 
6. INDIRECT INDUCTION OF AmpC BY PEPTI- 
DOGLYCAN 
In the final stages of peptidoglycan metabolism, E. 
coli liberates cell wall peptides from the glycan network 
of the murein due to the action of MarNAe-L-ala ami- 
dase [42]. Although some of the free cell wall peptides 
diffuse through the outer membrane porins most are 
recycled by the bacterium. Growing cells process the 
free cell wall peptides to L-ala-n-~,-glu-(l.)-m-A~pm 
(tripcptide), which is recovered in the cytoplasm as a 
uridine diphosphate (UDP)-activated peptidoglycan 
precursor (UDP-MurNAc-tripcptide) [43]. Therefore, 
cell wall peptides are recycled by a pathway that re- 
quires a membrane-bound tripeptide permgase and a 
cytoplasmic UDP-MurNAc:tripeptide ligase. 
Is it possible that the ampDE operon specifies en- 
zymes of cell wall peptide recycling? The accumulation 
of cell wall peptides found in ampD mutants can be 
explained if the AmpD protein functions as a UDP-  
MurNAc:tripeptid¢ ligase; by conveying tripeptides to 
metabolism, AmpD could determine the tripeptide con- 
centraticn. This postulate fits into a model for control 
of the inducible ampC gene. If the AmpR protein is 
regulated by binding the tripeptide, or a tripeptide me- 
tabolite, the ligand concentration would fluctuate in 
response to events that alter murein metabolism. Con- 
ceivably, ,8-1actams could indirectly induce the AmpC 
protein by disrupting marein synthesis and stimulating 
the murein hydrolases which produce the tripeptide. 
Therefore, a product of murein hydrolase activity is 
modelled into a regulatory circuit which controls AmpC 
synthesis (Fig. 3). 
Although the Opp protein contributes to the uptake 
of cell wall peptides, the primary role of Opp is in the 
transport of protein-derived peptidgs with L-amino 
acids and 0c-peptide bonds [44]. The unusual structure 
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Fig. 3. Recycling of cell wall peptides in E. coil. Peptides are liberated 
from the murein and processed to the tripeptide, L-ala-D-y-glu-(L).m- 
A:pm (tripeptide). which is coupled to a nucleolide.activated precur- 
sor of peptidoglycan biosynthesis. The process requires a tripeptide 
permease and a UDP-MarNAc:tripeptide ligase. Symbols: o, 
GIcNAc; c MurNAc;,  Ala;• Olu; II; A:pm. (See text for discussion. 
Modified from [43] with permission,) 
of cell wall peptides may necessitate a unique permease 
under conditions where Opp activity is saturated. A role 
for AmpE as a perrnease with specificity for tripeptides 
can explain conflicting reports that AmpE is either es- 
sential for AmpC induction [38] or dispensable [39]. In 
this way, the ampDE operon could exert dual control 
over cell wall peptide recycling and induction of the 
AmpC protein. 
Ar,-)C induction depends on several additional genes 
v,hici~ influence the structure of the cell envelope. At the 
time of c.~!i division in E. coil, the pbpA and ftsZ gene 
products are required to divert pel)tidoglycan synthesis 
from the lateral walls to the septum; temperature-sensi- 
tive mutants in each of these genes fail to induce the 
AmpC pr, -,.in from a cloned ampRC plasmid at the 
non-permissive t mperature [45,46]. The ampG muta- 
tion, u ,'~:,'t- d from ampC and am, oDE, exhibits a stably 
repress.~d pnenotype both in Enterobacler cloacae and 
the ampRC transformants of E. coli [47,48]. The AmpG 
protein carries several putative transmembrane regions 
and is therefore most likely an integral cytoplasmic 
membrane protein possibly acting as a ligand trans- 
porter (St=~an Normark, personal communication). 
Th~ Amp(} protein may also interact directly with 
AmpR [48]. Whether the AmpR protein controls ampC 
induction by sensing cell wall peptides or other compo- 
nents of murein metabolism remains to be discerned. 
However, these results lend support o the concept that 
AmpC induction may occur indirectly via pepddogly- 
can metabolites. 
7. UNIFYIN(} PERSPECTIVE 
The AmpR protein and the ampA attenuator exert 
unique mchanisms of control over ampC gen¢ expres- 
sion; how can they be rationalized in terms of the same 
AmpC gene product? An important r~lationship be- 
tween the two control processes i that the Stringent 
Response regulates the biogenesis of ribosomes, the 
synthesis of peptidoglycan, and the murein-lipoprotein 
[49]. Additionally, the product of the lee gene helps 
coordinate the translational pparatus with the pepti- 
doglycan synthetic machinery [50]. Therefore, control 
by growth rate could be exerted by mechanisms that 
monitor either the ribosomes or the peptidoglycan. By 
sensing peptidoglycan, AmpR could accommodate the 
AmpC protein both as an LV-peptidase and a p-lacta- 
mase through a dual response to growth rate and fl- 
lactam inducers. Since the ribosomes are not directly 
sensitive to penicillin, the genetical~.y inexpensive ampA 
attenuator may have evolved to employ the AmpC pro- 
tein solely as an LD-peptidase in the absence of any 
selective challenge by fl-lactam compounds. In this way, 
ampC gene expression isrationalized interms of control 
processes which exploit a functional duality in the 
AmpC protein. Indeed, a growing body of evidence 
demonstrates coordinate control of murein structure 
and AmpC synthesis. We hope the Lt>peptidas¢ anal- 
ogy will be of value both in discerning the physiological 
function of the AmpC protein and in the rational design 
of improved chemotherapeutic agents. In the treatment 
of many infectious diseases, effective inhibitors of 
AmpC e)~pression a d activity are urgently required. 
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